Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Digital Cognitive Training in Older Adults

11 novembre 2026 aggiornato da: Jihye Jung

Effect of a Physical Acticity-Integrated Digital Cognitive Training Program on Cognitive Function and Physical Performance in Community-Dwelling Older Adults

The purpose of this clinical study is to evaluate the effects of a digital cognitive training program combined with physical activity on the cognitive and physical functions of community-dwelling older adults. For older adults, maintaining both mental and physical health is essential for overall well-being. This study hypothesizes that combining tablet-based brain exercises with short, physical activities will help improve participants' memory, thinking skills, and physical abilities, such as balance and walking.

Researchers aim to enroll approximately 35 community-dwelling older adults who are 65 years of age or older and capable of walking. Participants will be randomly assigned to one of two groups:

  1. Standard Intervention Group: Participants will attend a 50-minute session once a week for 10 weeks. During each session, they will use a tablet device for cognitive training focused on memory, attention, and executive functions. This training will be paused three times per session for about 3 minutes each to perform low-intensity, physical activities to music.
  2. Extended Intervention Group: Participants will participate in the same 10-week digital cognitive training and physical activity program as the standard group. In addition, they will receive additional home-based cognitive activities to complete once a week.

To measure the effectiveness of the program, researchers will assess all participants before the program starts and after the 10-week program ends. Assessments will evaluate cognitive function, including memory and attention, as well as physical functions, such as grip strength, leg strength, balance, walking speed, and muscle mass.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

35

Fase

  • Non applicabile

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

65 anni e precedenti (Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Community-dwelling older adults aged 65 years or older.
  • Able to understand the purpose of the study and voluntarily consent to participate.
  • Cognitively intact or presenting with mild subjective memory complaints without a diagnosis of dementia (e.g., MoCA score ≥ 23 or MMSE score ≥ 24).
  • Able to walk independently without assistance (with or without assistive devices).
  • Able to understand instructions and perform cognitive and physical training programs using digital devices.

Exclusion Criteria:

  • Diagnosis of dementia or severe cognitive impairment.
  • Severe visual or hearing impairment that interferes with participating in digital training or assessment.
  • Acute or chronic neurological/musculoskeletal disorders that limit physical training (e.g., recent stroke, severe osteoarthritis).
  • History of severe cardiovascular disease or unmanaged hypertension/diabetes.
  • Current participation in other interventional clinical trials or similar cognitive/physical training programs.
  • Inability to follow study instructions due to severe psychiatric illness or communication difficulties.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Standard Intervention Group

Participants will receive a 50-minute session consisting of tablet-based digital cognitive training combined with physical activities once a week for 10 weeks.

A 10-week program where participants attend a 50-minute session once a week. Each session involves tablet-based digital cognitive training (focusing on memory, attention, and executive functions) combined with three 3-minute bouts of low-intensity, physical activities.

Sperimentale: Extended Intervention Group

Participants will receive the same 10-week program as the Standard Intervention Group (tablet-based digital cognitive training and seated physical activities). In addition, they will receive home-based cognitive activities to complete once a week.

A 10-week program combining a once-weekly 50-minute center-based session (tablet-based cognitive training and seated physical activities) with additional home-based cognitive activities to be completed once a week.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The Korean Version of Montreal Cognitive Assessment (MoCA-K)
Lasso di tempo: Baseline and 10 weeks

Cognitive function will be assessed using the Korean version of the Montreal Cognitive Assessment (MoCA-K). Total scores range from 0 to 30, where higher scores indicate better cognitive performance.

Baseline and 10 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The Short Physical Performance Battery (SPPB).
Lasso di tempo: Baseline and 10 weeks

Overall physical performance will be assessed using the Short Physical Performance Battery (SPPB). The SPPB evaluates lower extremity function through three components: standing balance, gait speed, and a 5-repetition chair stand test. Each component is scored from 0 to 4, yielding a total score ranging from 0 to 12. Higher scores indicate better physical function.

Baseline and 10 weeks
Change in Grip Strength
Lasso di tempo: Baseline and 10 weeks

Handgrip strength will be measured using a hand dynamometer. Results are recorded in kilograms (kg), where higher values indicate greater upper body muscle strength.

Baseline and 10 weeks
Change in Lower Extremity Strength
Lasso di tempo: Baseline and 10 weeks

Lower body strength will be assessed using the Five-times Sit-to-Stand test. Scores indicate the seconds of stands completed in 5 times, where a higher number indicates better lower extremity strength.

Baseline and 10 weeks
Change in Dynamic Balance
Lasso di tempo: Baseline and 10 weeks

Dynamic balance will be assessed using the Timed Up and Go (TUG) test. Results are measured in seconds, where a lower time indicates better mobility and dynamic balance.

Baseline and 10 weeks
Change in Static Balance
Lasso di tempo: Baseline and 10 weeks

Static balance will be assessed using the Balancia software by measuring COP sway path length under the eyes open and closed condition. Results are recorded in centimeters (cm), where lower values indicate better postural stability.

Baseline and 10 weeks
Change in Gait velocity
Lasso di tempo: Baseline and 10 weeks

Gait velocity will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters per second (cm/s), where higher values indicate better walking performance.

Baseline and 10 weeks
Change in Gait cadence
Lasso di tempo: Baseline and 10 weeks

Gait cadence will be assessed using the GAITRite electronic walkway system. Results are measured in steps per minute (steps/min), where higher values indicate better gait rhythm and coordination.

Baseline and 10 weeks
Change in Step Length
Lasso di tempo: Baseline and 10 weeks

Step length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better gait efficiency.

Baseline and 10 weeks
Change in Stride Length
Lasso di tempo: Baseline and 10 weeks

Stride length will be assessed using the GAITRite electronic walkway system. Results are measured in centimeters (cm), where higher values indicate better mobility.

Baseline and 10 weeks
Change in Skeletal Muscle Mass Index (SMI)
Lasso di tempo: Baseline and 10 weeks

Skeletal Muscle Mass Index (SMI) will be assessed using a Bioelectrical Impedance Analysis (BIA) device (InBody BWA). SMI is reported in kg/m², where higher values indicate greater skeletal muscle mass.

Baseline and 10 weeks
Change in Subjective Memory Complaints (SMCQ-K)
Lasso di tempo: Baseline and 10 weeks

Subjective memory complaints will be assessed using the Subjective Memory Complaints Questionnaire (SMCQ-K). Scores range from 0 to 14, where higher scores indicate a higher level of subjective memory impairment.

Baseline and 10 weeks
Change in Pain Intensity (NPRS)
Lasso di tempo: Baseline and 10 weeks

Pain intensity will be measured using the Numeric Pain Rating Scale (NPRS) for participants reporting pain. Scores range from 0 (no pain) to 10 (worst possible pain), where lower scores indicate reduced pain intensity.

Baseline and 10 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 novembre 2026

Completamento primario (Stimato)

1 febbraio 2027

Completamento dello studio (Stimato)

1 febbraio 2027

Date di iscrizione allo studio

Primo inviato

5 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

11 novembre 2026

Primo Inserito (Effettivo)

17 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • SYU 2026-09-027-002

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .